| Title | Description | Posting Date | Resource Type | Pay-per-view access |
| eDIRC Bulletin Vol. 4 (8) | Health Canada advisories regarding reports of infliximab and hepatosplenic T-cell lymphoma in pediatric and young adult patients, and increase in the rate of non-syndromic oral clefts and use of lamotrigine in pregnancy ; the Canadian Psychiatric Association`s 2006 guidelines for the management of anxiety disorders ; online links to issues of Hospital Pharmacist, American Family Physician, CFP, CMAJ, and BMJ. | Aug. 28, 2006 | Email Bulletins | $0.00 |
| eDIRC Bulletin Vol. 4 (7) | Health Canada advisories regarding reports of tipranavir and intracranial hemorrhage, reports of erectile dysfunction medications and visual disturbances, and a recent study published in NEJM on use of ACEI`s during pregnancy ; Canadian Adverse Reaction Newsletter on the rationale and importance for reporting ADR`s in children ; online links to Bandolier, Institute for Safe Medication Practices Canada (ISMP) bulletins, issues of Hospital Pharmacist, Canadian Family Physician (CFP), Aerican Family Physician (AFP), and CMAJ. | Aug. 21, 2006 | Email Bulletins | $0.00 |
| Therapeutic Options : Focus on Atrial Fibrillation | Classification, pathophysiology and risk factors, management approach, drugs used for rhythm control, rate control, prevention of thromboembolism, antithrombotic therapy algorithm for patients with atrial fibrillation. | July 26, 2006 | Therapeutic Options | $5.30 |
| New Drugs/Drug News Jul/Aug 2006 | Medications in the Pipeline – Duloxetine (Cymbalta), entecavir (Baraclude), Anya, Seasonale, exenatide (Byetta), inhaled insulin (Exubera), r-flurbiprofen (Flurizan), rimonabant (Acomplia), varenicline (Chantix). | July 26, 2006 | New Drugs/Drug News | $5.30 |
| DIRC Update : West Nile Virus 2006 | Transmission, symptoms, treatment and prevention, including list of registered insect repellents in Canada and insect repellent counselling tips. | June 20, 2006 | Public Resources | $0.00 |
| eDIRC Bulletin Vol. 4 (5) | University of Arizona Center for Education and Research on Therapeutics` list of drugs that can potentially prolong the QT interval ; Health Canada Advisory on raloxifene and increase in the incidence of deaths due to stroke in individuals at risk of cardiovacular disease ; CADTH`s information regarding use of the investigational vaccine Zostavax for the prevention of shingles and postherpetic neuralgia ; the Public Health Agency of Canada`s guidelines for the prevention and treatment of sexually transmitted infections, and updated recommendations for the routine use of Pneumococcal conjugate vaccine for infants. | June 16, 2006 | Email Bulletins | $0.00 |
| eDIRC Bulletin Vol. 4 (4) | Canadian Adverse Reaction Newsletter on reports of acute renal failure & tenofovir, and on reports of vascular disorders & MI with use of isotretinoin; Health Canada Advisory on gatifloxacin contraindication in patients with diabetes; OCP update on the rescheduling of pseudoephedrine and ephedrine; American Association of Endodontist`s position statement regarding bisphosphonate-induced osteonecrosis of the jaw; National OB/GYN Society`s new recommendation regarding Depo-Provera and link to loss of bone density. | May 26, 2006 | New Drugs/Drug News | $5.30 |
| New Drugs/Drug News May/Jun 2006 | Insulin Therapy – Frequently Asked Questions. | May 25, 2006 | New Drugs/Drug News | $5.30 |
| eDIRC Bulletin Vol. 4 (3) | Canadian Adverse Reaction Newsletter on tenofovir & reports of acute renal failure, and isotretinoin & reports of vascular disorders and MI ; OCP update on the rescheduling of pseudoephedrine and ephedrine. | Apr. 28, 2006 | Email Bulletins | $0.00 |
| New Drugs/Drug News Mar/Apr 2006 | Epinephrine Injection (Twinject) : Background, approved indications, pharmacology, efficacy, adverse reactions and precautions, drug interactions, dosage and administration, availability and cost, place in therapy. | Mar. 20, 2006 | New Drugs/Drug News | $5.30 |
| eDIRC Bulletin Vol. 4 (2) | Canadian Adverse Reaction Newsletter reports on concurrent use of warfarin & oseltamivir and increase in INR, and use of rosiglitazone & parotid gland enlargenment ; Health Canada advisories regarding WinRho SDF & intravascular hemolysis, and telithromycin & liver failure ; NEJM articles on gatifloxacin & potentially serious glycemic reactions, and calcium plus vitamin D & risk of hip fracture ; CDC guidelines for influenza vaccination of health-care personnel ; links to Australian Prescriber and WHO Pharmaceuticals Newsletter. | Mar. 6, 2006 | Email Bulletins | $0.00 |
| eDIRC Bulletin Vol. 4 (1) | DIRC articles on Pharmacotherapy for Carpal Tunnel Syndrome and Lateral Epicondylitis, and Bipolar Disorder in Women ; Health Canada Warnings and Advisories ; American College of Chest Physicians` guidelines on treatment of acute cough and upper airway cough syndrome ; approval of Exubera inhaled insulin in the United States. | Feb. 15, 2006 | Email Bulletins | $0.00 |
| Therapeutic Options : Focus on Bipolar Disorder in Women | General considerations, pregnancy and treatment considerations, breastfeeding and treatment considerations, FAQs. | Feb. 13, 2006 | Therapeutic Options | $5.30 |
| New Drugs/Drug News Jan/Feb 2006 | Docosanol 10% Cream (Abreva) : Background, approved indications, pharmacology, evidence of efficacy, adverse reactions and precautions, drug interactions, dosage and duration, cost comparison, counseling tips, place in therapy, conclusion, references. Cumulative index 2000 to 2005. | Feb. 13, 2006 | New Drugs/Drug News | $5.30 |
| WSIB : Drug News Update, Winter 2005 | Pregabalin (Lyrica) : Pharmacology, efficacy, adverse effects and precautions, drug interactions, dosage and administration, place in therapy. | Feb. 13, 2006 | WSIB Newsletter | $5.30 |
| WSIB : Drug News Update, Fall 2005 | Pharmacotherapy for Carpal Tunnel Syndrome and Lateral Epicondylitis : Corticosteroids, other medications, non-pharmacological therapy. | Feb. 13, 2006 | WSIB Newsletter | $5.30 |
| eDIRC Bulletin Vol. 3 (13) | DIRC overview on pregabalin (Lyrica) ; Therapeutic Options articles on influenza & influenza vaccination, and benign prostatic hyperplasia ; Health Cdanada Advisories include contraindication of letrozole (Femara) in premenopausal women, as well as during pregnancy/lactation ; OPA information on changes to the drug benefits administered by Green Shield. | Dec. 16, 2005 | Email Bulletins | $0.00 |
| Therapeutic Options : Focus on Benign Prostatic Hyperplasia | Focus on Benign Prostatic Hyperplasia – Definition, diagnosis, treatment strategies, special situations, useful websites. | Dec. 15, 2005 | Therapeutic Options | $5.30 |
| New Drugs/Drug News Nov/Dec 2005 | Pregabalin (Lyrica) : Backgound information, approved indications, pharmacology, pharmacokinetics, efficacy, summary of pregabalin trials, adverse events and precautions, drug interactions, dosage and administration, place in therapy, availability and cost. | Dec. 7, 2005 | New Drugs/Drug News | $5.30 |
| eDIRC Bulletin Vol. 3 (12) | Avian influenza FAQs ; Health Canada advisories on atomoxetine & increased risk of self harm, and paroxetine & increased risk of congenital malformations in the first trimester of pregnancy ; AstraZeneca announcement of the discontinuation of quetiapine ; Australian Prescriber`s article on the use of pychotropic medications in children ; BMJ`s perspective regarding the risks of the avian flu. | Nov. 8, 2005 | Email Bulletins | $0.00 |
